Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07524946 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Assess Safety, Pharmacokinetics, and Treatment Effect of Cabtreo

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Trial sites expanded: 0 → 15 locations · Start date changed from estimate of Apr 2026 to Apr 1, 2026v2 Show 2 more changesShow less
    • Trial sites expanded: 0 → 15 locations
    • Start date changed from estimate of Apr 2026 to Apr 1, 2026
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study is to evaluate the safety, pharmacokinetics, and treatment effect for topically applied CABTREO lotion in pediatric participants ages 9 to 11 years, 11 months with Acne Vulgaris.
Trial Details
NCT Number NCT07524946
Lead Sponsor Bausch Health Americas, Inc.
Collaborators: MedTrials Incorporated
Conditions Acne Vulgaris
Enrollment 100 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov